The Work We Fund

Funded projects
1,250+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programs
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programs.

The Movember Revolutionary Team Award: Prostate Cancer Metastasis (ProMis): New Opportunities for Therapeutic Development

Movember Funding to Date

AUD 5,000, 000

What we seek to achieve

These discoveries will revolutionise the treatment and life of men with prostate cancer by finding new ways to prevent cancer growth in bones and prolong the lives of men living with advanced prostate cancer.

Country
Australia
Implemented by
Movember Foundation and Prostate Cancer Foundation of Australia
Project start date
July 2014
Project Status
Project Complete

About the project

ProMis (prostate metastasis) uniquely brings together applicants with diverse skills and proven track records in the molecular biology of cancer and tumour/bone environment interactions in the clinical setting and in pre-clinical models. The team has developed unique clinical cohorts and animal models of dormancy, new single cell imaging techniques to identify individual dormant cancer cells in bone, single cell genomic/transcriptomic techniques and informatics pipelines.

The end goal of this program is to identify critical mechanisms responsible for regulating dormancy, tumour growth in bone and metastasis, determine whether existing drugs can be used more effectively, develop new treatments and pave the way for a clinical program that will impact directly on patient care, via better clinical management and survival of men with advanced disease.

The ProMis management committee has also established a scientific advisory board (SAB) comprising senior experts with expertise in both clinical and basic prostate cancer research.

>
Page 1 of 29